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Optical coherence tomography  
angiography — novel method to access  
retinal microcirculation in patients  
with diabetic retinopathy
ABSTRACT
Introduction. Optical coherence tomography an-
giography (OCTA) is a novel technique that allows 
visualization of retinal capillary network without the 
need for contrast usage. Being easy to perform and 
non-invasive, it might become significantly competitive 
to fluoroangiography. 
Material and methods. The study included 45 patients 
(90 eyes) with diabetes type 1 and 2 and nonprolifera-
tive and proliferative diabetic retinopathy as well as 
35 healthy volunteers (70 eyes) as a control group. 
Beside full ophthalmic examination, all patients under-
went OCTA (RTVue XR Avanti; Optovue) examination. 
Obtained images were used to assess the presence of 
morphologic changes of the retina characteristic for 
diabetic retinopathy (capillary density and regularity as 
well as occurrence of microaneurysms, ischemic areas, 
intraretinal microvascular abnormalities and neovas-
cularizations). The assessment was carried out on two 
levels of retinal capillary plexus. Additionally, measure-
ment of foveal avascular zone (FAZ) was performed. 
The results were compared with those obtained from 
the control group.
Results. All examined eyes in the studied group exhib-
ited one or more anomalies characteristic of diabetic 
retinopathy as seen on the OCTA scans, both in superfi-
cial and deep vascular plexus. In the control group we 
have detected capillary irregularity (9% in a superficial 
and 11% in a deep vascular plexus) and capillary rare-
fication (7% in a superficial and 9% in a deep vascular 
plexus) and no other anomalies were found. Mean FAZ 
area measured in superficial vascular plexus was 382 ± 
± 134 square micrometers and was significantly larger 
(p < 0,001) in comparison to the control group (259 ± 
± 103 square micrometers).
Conclusions. Optical coherence tomography angiogra-
phy is a useful diagnostic tool used to assess vascular 
changes in the retinal microcirculation in diabetic pa-
tients. Its main advantages are noninvasiveness, repeat-
ability and a high quality of images acquired from the 
chosen level of the retina. (Clin Diabet 2016; 5, 3: 77–82)
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Introduction
Diabetes is oftentimes vividly defined as a disease 
of blood vessels. The negative influence of chronic, 
drawn-out hyperglycemia on microcirculation is well 
documented in literature reports [1]. Blood flow distur-
bance in small caliber vessels associated with perma-
nent hyperglycemia affects all organs, but is easiest to 
observe within the eye. This is because vitreous body 
is transparent and, with adequate optical equipment, 
we can effortlessly and precisely assess the degree of 
vascular changes in the fundus of the eye. This fact 
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has been known for years, although ongoing tech-
nological progress gives us access to unprecedented 
possibilities [2].
Retinopathy is a relatively common complication 
of diabetes. In screening studies conducted amongst 
patients with at least 5 years history of diabetes, over 
50% exhibit changes in the fundus of the eye typical 
for the disease [3]. Although a significant progression 
of retinopathy occurs only in a relatively small group of 
patients, we are not able to predict who will be affected 
by it. Because of this a full ophthalmic examination 
is periodically performed in all patients with changes 
in the fundus of the eye [4]. Postponing the onset of 
laser therapy is a mistake, as this method of treatment 
is the only effective way of saving vision in diabetic 
retinopathy. Thus, the cost of monitoring progression 
of retinal vascular changes in diabetic patients is sig-
nificant and there is much need for simplification of 
associated procedures, while maintaining their sensitiv-
ity and precision.
Every patient with diabetes — both type 1 and type 2 
— should annually undergo an eye examination with 
thorough assessment of the fundus of the eye, per-
formed after pupil dilatation [4]. Some patients present 
changes that require further investigation. Currently, 
the gold standard for retinal circulation assessment is 
fluorescein angiography (FA). It is an invasive and time 
consuming procedure. Furthermore, complications af-
ter intravenous application of fluorescein — however 
rare — can be threatening, e.g. anaphylactic shock. If 
these occur, further FA’s are contraindicated in such 
patients. Consequently, the procedure is forfeited more 
often than it should be. This of course increases the risk 
of introducing the laser therapy too late. 
For a couple of years now there has been intensive 
ongoing research concerning creation of new imaging 
methods for the fundus of the eye, without the need of 
using contrast. Techniques based on optical coherence 
tomography, which is currently at its golden age, proved 
to be most promising. Optical coherence tomography 
angiography (OCTA) is a method that operates on a 
basis of imaging the movement of erythrocytes in blood 
vessels, enabling a visualization of vascular network of 
both the retina and the choroid (Fig. 1). The examination 
takes from several to several dozen seconds and does not 
require pupil dilatation. It can be performed repeatedly 
without any threat to the patient.
Study goal
The goal of the study was to asses retinal micro-
circulation using the optical coherence tomography 
angiography in patients with diabetes and diabetic 
retinopathy in different progression stages.
Material and methods
The study was conducted in Diabetology Outpa-
tient Clinic of N. Barlicki University Hospital No. 1 in 
Lodz from 23.02.2015 to 21.03.2015. Observations 
were performed in in accordance with the study pro-
tocol in all patients with type 1 and type 2 diabetes 
visiting the clinic consecutively, who met the inclusion 
criteria. Based on medical history and blood tests results 
from month prior to the start of the study, patients with 
HbA1c > 8.5%, renal insufficiency, smokers and those 
previously treated with laser therapy or anti-VEGF, were 
excluded from the study.
Qualified patients underwent a full ophthalmic 
examination. Based on its results, the next phase of 
the study included patients with transparent visual 
pathway and clinical signs of diabetic retinopathy, both 
proliferative and non-proliferative. 
A control group was formed from recruited vol-
unteers, matched by gender and age, non smokers, 
without prior history of ophthalmologic treatment of 
any kind, with no abnormalities present in an ophthal-
mologic examination. 
Eventually the study group (group 1) consisted of 45 
patients (90 eyes), 22 men (49%) and 23 women (51%) 
aged from 31 to 82 (mean age: 64 ± 13). The control 
group (group 2) was formed by 35 persons (70 eyes) 
without diabetes, 19 women (54%) and 15 men (46%) 
aged from 35 to 75 (mean value 62 ± 9). Mean diabetes 
duration time in the study group stood at 11 ± 7.4 years.
Every person included in the study underwent 
an OCTA (RTVue XR Avanti; Optovue) examination. 
Figure 1. Example image of fovelar area obtained with OCTA 
method
Małgorzata Loba et al., Optical coherence tomography angiography
79
The device performed 70 000 A-scans per second on a 6 × 
× 6 mm area surrounding the fovea, on two levels 
of deep and superficial retinal capillary plexus. Using 
the SSADA (Split-Spectrum Amplitude Decorrelation 
Angiography) algorithm, the machine detects red 
blood cells flow in order to visualize the capillary net-
work. The image is then laid over a two dimensional 
map of the retina acquired with SSOCT (Swept-source 
Optical Coherence Tomography) in EN FACE 3D mode. 
The scanning procedure of one eye took 20 seconds 
on average. The examination was performed without 
pharmacological pupil dilatation.
Acquired angiographic images were assessed and 
compared in regard of sings that in classical FA exami-
nations are characteristic of diabetic retinopathy. Dis-
turbance in vascular architecture is the most prominent 
feature of diabetic retinopathy. Therefore, the regularity 
and density of the capillary network were assessed. In 
extreme cases, lack of capillaries indicates the presence 
of ischemic areas. Microaneurysms — bulges on the 
vascular wall — visible clinically as reddish points and 
angiographically as point-like, hyperfluorescent areas, 
are also typical for diabetes. Their numbers increase 
along with the progression of diabetic changes. Pres-
ence of intraretinal microvascular abnormalities (IRMA) 
— invalid arteriovenous anastomoses in low perfusion 
areas - and neovascularisations (NVE) — pathological, 
newly formed vessels — indicates progression to pre-
proliverative and proliferative retinopathy respectively.
All parameters were assessed both on deep and su-
perficial levels of the retinal plexus. The superficial plexus 
spreads from the inner limiting membrane to the inner 
plexiform layer which adds up to approximately 120 mi-
crons. This layer encompasses main retinal vessels, with 
capillaries decreasing in diameter towards the macula, 
creating concentric junctions that resemble a spider’s 
web. Meanwhile, the deep plexus consists of the further 
60 microns up to the outer plexiform layer. It includes 
lesser capillaries with multiple connections and similar 
diameter throughout the area, creating fanlike branches 
around the foveal avascular zone. Many anastamoses 
connect these two plexi, perpendicular to their surface.
Additionally, the surface of the foveal avascular 
zone (FAZ) was measured for the superficial layer 
using an Image J (NIMH, Bethesda, USA) graphic pro-
gram. The FAZ is an area surrounding the fovea and 
completely deprived of vessels, it can only be properly 
assessed using angiographic images. Physiologically, 
its surface area peaks at approximately 270 square mi-
crometers and may increase in some vascular diseases 
of the retina [5]. 
Statistical analysis was performed with the use of 
parametric and non-parametric tests. Calculations were 
carried out assuming a = 0.05 statistical significance 
level and using Microsoft Excel and Addinsoft XLStat 
2008 software. This study was approved by the Bioeth-
ics Committee of the Medical University of Lodz (Dec 
nr. RNN/328/15/KE).
Results
All of the tested eyes of patients in the group 1 
displayed one or more features characteristic for 
diabetic retinopathy, using the OCTA examination, on 
both retinal levels that were examined. In the group 2, 
none of the eyes displayed microaneurysms, ischemic 
areas, IRMA or NVE, however the capillary network 
was assessed as irregular — in 9% on superficial level 
and 11% on deep level — or rareficated — in 7% on 
superficial and 9% on deep level. Figure 2 shows an 
illustrative angiogram showing features characteristic 
of diabetic retinopathy in OCTA imaging.
Table 1 presents a summary of morphological fea-
tures of the superficial and deep plexi. A comparison 
of morphological parameters of capillary networks 
between the groups of diabetic patients and the con-
trol group showed a statistically significant difference 
on both superficial and deep vascular plexus levels for 
every assessed parameter (p < 0.05).
The mean surface area of FAZ measured on the 
superficial level in the group 1 was 382 ± 134 square 
micrometers and was significantly larger than in the 
group 2, which presented a mean area of 259 ± 103 
square micrometers. This correlations were statisti-
cally significant (p < 0.001). An example image of an 
enlarged FAZ in a patient with diabetic retinopathy 
in comparison to a healthy individual is presented in 
Figure 3.
Discussion
A novel angiographic technique based on optical 
coherence tomography is the next milestone in the 
vascular diseases of the retina diagnosing process. Its 
viability increases in patients who require numerous, 
repeatable examinations. This applies especially to 
patients with diabetic retinopathy, as its progression 
stage may require introducing laser therapy at any 
time. Results of this study prove that OCTA is capable 
of detecting and imaging vascular abnormalities in the 
retina characteristic of diabetic retinopathy. However it 
remains an open question, if it can be a serious compe-
tition to fluorescein angiography as the gold standard 
for diagnosing vascular diseases of the retina. 
Previous studies comparing OCTA angiograms with 
classic FA images show many benefits of the former [6, 7]. 
First of all, OCTA angiograms feature high resolu-
tion. Obtained images present an uncanny quality in 
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mapping the smallest capillary network surrounding 
the macula, which enables a visualization of minimal 
structural abnormalities [6, 8]. This could potentially 
lead to diagnosing vascular changes in diabetic patients 
much earlier than it is currently possible, but would 
also require performing OCTA on a large group of 
patients [9]. Another formidable advantage of OCTA 
when compared to FA is the ability to obtain images 
from various layers of the retina. This is a whole new 
quality, as it has thus been impossible to differentiate 
the deep and superficial vascular plexus in an image. 
Differences in progression of changes in these layers 
have not been thoroughly examined yet and their 
significance is still ambiguous, but they may serve as 
starting point to further studies on the diabetic retino-
pathy patomechanism.
However, some shortcomings of this new method 
should still be noted. FA holds an evident advantage 
in visualizing capillary leaks and microanuerysmal 
leakiness [6, 7]. This is of significance because these 
signs determine the decision to introduce focal laser 
therapy or anti-VEGF treatment. Nonetheless, OCTA 
may greatly reduce the numbers of performed FA ex-
aminations, enabling easier access to FA for patients 
who absolutely need it. 
A fundamental difference between OCTA and FA 
is the way in which the information regarding vascular 
blood flow is obtained. Fluoroscein angiography uti-
lizes contrast in order to do so. This makes pathologies 
related to dye accumulation, such as microaneursyms, 
more visible. On the other hand, OCTA operates on 
detecting movement of blood cells — in other words, 
Figure 2. An angiogram showing characteristic features of diabetic retinopathy in OCTA imaging. The left side shows superficial 
layer images, with deep layer images on the right. Bottom scans present an angiographic image superimposed on top of an 
OCT en face scan
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Table 1. A comparison of morphological features of the deep and superficial retinal vascular plexus in diabetic retinopathy 
patients (group 1) and healthy individuals (group 2)
Morphological features Superficial vascular plexus Deep vascular plexus
Group 1 Group 2 Group 1 Group 2
Capillary network structure n % n % n % n %
Regular 31 34 64 91 32 36 62 89
Irregular 59 66 6 9 58 64 8 11
Density of capillary network
Dense 15 16 65 93 12 13 64 91
Moderately dense 34 38 5 7 26 29 6 9
Rarificated 41 45 0 0 52 58 0 0
Presence of microaneurysms
None 5 6 70 100 14 16 70 100
Singular 33 37 0 0 34 38 0 0
Multiple 52 58 0 0 42 47 0 0
Ischemic areas
None 65 72 70 100 52 58 70 100
Singular 18 20 0 0 27 30 0 0
Multiple 7 8 0 0 11 12 0 0
IRMA
None 31 34 70 100 24 27 70 100
Singular 51 57 0 0 58 64 0 0
Multiple 8 9 0 0 8 9 0 0
Neovascularisations
None 50 56 70 100 44 49 70 100
Singular 35 39 0 0 39 43 0 0
Multiple 5 6 0 0 7 8 0 0
IRMA — intraretinal microvascular abnormalities
Figure 3. Example image of foveal avascular zone (FAZ) — in red — in a healthy individual (A) and an enlarged one in a patient 
with diabetic retinopathy (B)
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an active blood flow — which results in the inability 
to detect leaking or congestion. However, this may be 
both beneficial and disadvantageous. While contrast 
accumulation in FA causes some details behind the 
given area to be obscured, there is no such problem in 
OCTA, as visualization of vascular changes is presented 
separately for each level. 
The results of this study seem to confirm these as-
sumptions. In regard of the superficial layer there were 
43% of patients and in regard of the deep layer 54% of 
patients in the group 1 that showed only isolated or none 
at all microaneurysms, while clinical assessment dis-
closed them in every patient in this group. The reason for 
this discrepancy may be the low blood flow through the 
microaneurysms or flow of the serum without morphotic 
elements, which makes detecting them with decorela-
tion method impossible. Numbers of microanerusyms 
lower than expected while using OCTA examinations 
were also reported by other authors [6, 8, 9].
In contrast to FA, a relatively small surface area of 
the examination (3 × 3 mm or 6 × 6 mm) is a serious 
limitation of OCTA. This is due to problems of technical 
nature. However, there are works in progress aimed to 
increase the area accessible to the method, which in the 
near future may also enable covering peripheral parts of 
the fundus of the eye. It should be noted that patients 
with reduced transparency of the optical pathway — 
for instance, with cataracts — won’t be able to fully 
benefit from this method. 
Retinal microcirculation assessment is non-para-
metric in both OCTA and FA examinations. Capillary 
rarerifcation or irregularity was present in 10% of 
patients from the control group on both capillary plexi 
levels. With OCTA providing an image so detailed — 
showing the tiniest of capillaries — some range of ana-
tomical variations is expected to be present, as it had 
not been described yet due to novelty of the method. 
FAZ surface area is an important feature that can be 
easily measured and assessed using the OCTA method. 
This study disclosed a significant expansion of this area 
in patients with diabetic retinopathy. Other studies using 
the FA method confirmed that the increase in FAZ sur-
face is a factor significantly correlated with progression 
of diabetic retinopathy and can be used to ascertain its 
progression level. However, using FA seemed too burden-
ing at the time, because of the invasive nature of the 
procedure. Currently, OCTA enables a regular FAZ assess-
ment in diabetic patients. Further studies are necessary 
to evaluate the utility of this parameter in assessment 
of diabetic retinopathy progression [10, 11].
In conclusion, it is worth noting that the condition of 
retinal and choroidal circulation can be an important in-
dicator of general state of blood vessels of the individual. 
Thus, being relatively easy to perform and non-invasive, 
OCTA may become a valuable procedure in systemic 
diseases such as atherosclerosis, hypertension, cerebral 
stroke, renal diseases or other vascular diseases [12].
Conclusions
OCTA is a useful diagnostic tool used to assess 
vascular changes in the retinal microcirculation in dia-
betic patients. Its main advantages are noninvasiveness, 
repeatability and a high quality of images acquired from 
the chosen level of the retina.
OCTA provides a detailed imaging of foveal avas-
cular zone and can confirm the presence of features 
characteristic of diabetic retinopathy, such as ischemic 
areas, IRMA or NVE. Despite its limitations, it may 
become an important additional tool in diagnosing 
diabetic retinopathy.
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